GlassScriptPhysician profile
Abby Culver
NPI 1467848804
$6,779.12
in general payments reported to CMS, 2019-2025
19 companies · $3,397 in 2025
The $3,397 reported for 2025 was more than what 89% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,112 · 2022: $837 · 2023: $680 · 2024: $754 · 2025: $3,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,728 · Travel and Lodging: $1,015 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,728.22 |
| Travel and Lodging | $1,015.20 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $2,445.09 | 2025 | |
| Bard Peripheral Vascular, INC. | $711.23 | 2021 | |
| Abbvie INC. | $668.29 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $557.59 | 2021-2022 | |
| Stryker Corporation | $509.90 | 2021-2023 | Spy-Phi System, Optablate |
| Tela Bio, INC. | $381.19 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $314.34 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Dilon Technologies, INC. | $259.32 | 2025 | Hemoblast Bellows |
| Access Pro Medical, LLC | $233.24 | 2022 | |
| Galderma Laboratories, L.P. | $149.43 | 2025 | Dysport |
| Davol INC. | $142.13 | 2022 | |
| Medical Device Business Services, INC. | $124.32 | 2025 | Dermabond |
| Rti Surgical, INC | $83.33 | 2024 | |
| Allergan, INC. | $51.77 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $46.00 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $33.80 | 2025 | Ligasure |
| Revance Therapeutics, INC. | $30.81 | 2025 | Daxxify |
| Merz North America, INC. | $20.40 | 2024 | |
| Kci USA, INC. | $16.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Culver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.